+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Lung Cancer"

Market Spotlight: Small-Cell Lung Cancer (SCLC) - Product Thumbnail Image

Market Spotlight: Small-Cell Lung Cancer (SCLC)

  • Report
  • November 2020
  • 49 Pages
  • Global
Non-Small Cell Lung Cancer KOL Interview - NH, US - Product Thumbnail Image

Non-Small Cell Lung Cancer KOL Interview - NH, US

  • Report
  • August 2018
  • 10 Pages
  • United States
From
Datamonitor Healthcare Non-Small Cell Lung Cancer KOL Interview - NY, US - Product Thumbnail Image

Datamonitor Healthcare Non-Small Cell Lung Cancer KOL Interview - NY, US

  • Report
  • August 2018
  • 10 Pages
  • United States
From
Perspectives in Lung Cancer - Product Thumbnail Image

Perspectives in Lung Cancer

  • Book
  • July 2020
From
From
From
From
Precision Medicine in Oncology. Edition No. 1 - Product Thumbnail Image

Precision Medicine in Oncology. Edition No. 1

  • Book
  • October 2020
  • 288 Pages
Oncology. Edition No. 1. Mount Sinai Expert Guides - Product Thumbnail Image

Oncology. Edition No. 1. Mount Sinai Expert Guides

  • Book
  • October 2019
  • 632 Pages
Oncology. Edition No. 3. Lecture Notes - Product Thumbnail Image

Oncology. Edition No. 3. Lecture Notes

  • Book
  • January 2016
  • 368 Pages
Lung Cancer. Edition No. 4 - Product Thumbnail Image

Lung Cancer. Edition No. 4

  • Book
  • May 2014
  • 616 Pages
Loading Indicator

Lung cancer is a type of cancer that originates in the lungs. It is the leading cause of cancer-related death worldwide. Oncology is the branch of medicine that deals with the diagnosis, treatment, and prevention of cancer. Lung cancer is one of the most common types of cancer treated by oncologists. Treatment options for lung cancer include surgery, chemotherapy, radiation therapy, and targeted therapy. The lung cancer market is a rapidly growing segment of the oncology market. It is driven by the increasing prevalence of lung cancer, advances in treatment options, and the increasing availability of targeted therapies. The market is expected to continue to grow in the coming years due to the increasing demand for better treatments and the development of new therapies. Some companies in the lung cancer market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more